The report predicts the global Microbial Identification Market to grow with a CAGR of 12.2% over the forecast period from 2022 to 2031.
The global microbial identification market size is estimated to be USD 3.2 billion in 2020 and is projected to reach USD 5.7 billion by 2031, at a CAGR of 12.2%. Growth in this market is largely driven by the rising incidence of infectious diseases and the increasing frequency of pandemics, technological advancements, increasing food safety concerns, and increasing government initiatives and funding to detect and control antimicrobial-resistant species
“By consumables type segment, the panels/ID cards & media segment accounted for the fastest growing consumable segment of the microbial identification market”
On the basis of product & service type, the consumables segment is further segmented into panels/ID cards & media, kits, and other consumables. The panels/ID cards & media accounted for the fastest-growing segment of the consumables segment. Panels, ID cards, and media enable the easy and rapid identification of microorganisms and are a key factor driving market growth
“By application, the diagnostic applications segment accounted for the largest share of the microbial identification market”
Based on application, the microbial identification market is categorized into six segments— diagnostic applications, pharmaceutical applications, food testing, beverage testing, cosmetics, and personal care products testing, environmental applications, and other applications. The diagnostic applications accounted for the largest share of the application segment due to the increasing use of microbial identification to diagnose infectious diseases in humans and animals.
Request The Sample PDF Report Here Fore More Insights: https://www.sdki.jp/sample-request-59148
“Asia Pacific: The fastest-growing region in the microbial identification market.”
The Asia Pacific region is estimated to grow at the highest CAGR in the microbial identification market during the forecast period, this is mainly due to the improving healthcare infrastructure, the heavy burden of infectious diseases, growing initiatives to control the spread of infectious diseases, and increasing investments by leading players in this region
“North America: the largest share of the microbial identification market”
North America accounted for the largest share of the microbial identification market. Technological advancements in microbial identification, the increasing prevalence of infectious diseases, growing food safety concerns, and the presence of prominent players are the major drivers of the North American market.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
• By Respondent– Supply Side- 80%, Demand Side-20%
• By Designation— CXOs – 20%, Executives – 25%, Mangers – 55%
• By Region— North America – 45%, Europe – 20%, APAC – 25%, RoW- 10%
The microbial identification market is dominated by a few globally established players such as bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Bruker Corporation (US), Shimadzu Corporation (Japan), QIAGEN NV (Netherlands), Biolog, Inc. (US), Avantor, Inc. (US), Accelerate Diagnostics, Inc. (US), Liofilchem S.r.l. (Italy), Trivitron Healthcare (India), Gradian Diagnostics (US), Alifax S.r.l. (Italy), Himedia Laboratories (India), I2A SA (France), Zhuhai DL Biotech Co., Ltd. (China), Genefluidics, Inc. (US), Creative Diagnostics (US), Synoptics Ltd. (UK), Novacyt Group (France), vermicon AG (Germany), and ELITechGroup (France), and PromoCell GmbH (Germany)
Click Here To Get The Sample PDF Report: https://www.sdki.jp/sample-request-59148
The report segments the microbial identification market based on region (Asia Pacific, Europe, North America, and RoW), product & service (instruments & software, consumables, and services), method (phenotypic, proteomic-based, and genotypic), technology (mass spectrometry, PCR, flow cytometry, microscopy, and other microbial identification technologies), application (diagnostic applications, pharmaceutical applications, food testing, beverage testing, cosmetics, and personal care products testing, environmental applications, and other applications), end-user (hospitals, diagnostic laboratories, and blood banks; pharmaceutical companies & CROs; food manufacturing companies; beverage manufacturing companies; and other end users). The report also provides a comprehensive review of market drivers, restraints, opportunities, challenges, and trends in the microbial identification market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the microbial identification market and provides them information on key market drivers, restraints, challenges, opportunities, and trends.
–Related Trending Reports:-